Epidermal necrolysis as the presenting manifestation of pediatric lupus

2020 ◽  
Vol 37 (6) ◽  
pp. 1119-1124
Author(s):  
Dharmagat Bhattarai ◽  
Pandiarajan Vignesh ◽  
Himanshi Chaudhary ◽  
Niteesh Bharadwaj ◽  
Lokesh Saini ◽  
...  
Keyword(s):  

2014 ◽  
Vol 66 ◽  
pp. S49-S50 ◽  
Author(s):  
Reut Gurion ◽  
Vin Tangpricha ◽  
Eric Yow ◽  
Laura E. Schanberg ◽  
Grace McComsey ◽  
...  


1997 ◽  
Vol 29 (3) ◽  
pp. 355-361 ◽  
Author(s):  
Susan F. Massengill ◽  
Claire Hedrick ◽  
Elia M. Ayoub ◽  
John W. Sleasman ◽  
Kuo Jang Kao




2020 ◽  
Vol 7 (2) ◽  
pp. 205510292097771
Author(s):  
Kathleen Kenney-Riley ◽  
Shari Salzhauer Berkowitz ◽  
Kimberly Rapoza

The current study examines depression and pain as potential contributors to patient-provider discordance in the assessment of lupus disease activity. The study conducted a secondary analysis of data obtained from the Childhood Arthritis and Rheumatology Research Alliance registry, with N = 859 adolescent participants. Assessments of pain, disease activity, and antidepressant medication use were collected from the patient and provider. Results indicated that depression might be underdiagnosed in pediatric lupus patients. While psychotropic medication and pain scores were independently related to greater patient-provider discordance regarding health status, pain mediated this relationship. Implications for treatment outcomes are discussed.



2019 ◽  
Author(s):  
Ankita Singh ◽  
Rakesh Pilania ◽  
Sandesh Guleria ◽  
Nameirakpam Johnson ◽  
Gummadi Anjani ◽  
...  


2020 ◽  
Vol 3 (1) ◽  
pp. 34-43
Author(s):  
Jessy J Alexander ◽  
Alexander Jacob ◽  
Anthony Chang ◽  
Richard J Quigg ◽  
James N Jarvis

Abstract Systemic lupus erythematosus (SLE) is an autoimmune disease that is a challenge to diagnose and treat. There is an urgent need for biomarkers to help define organ involvement, and more effective therapies. A unique population of T cells, the CD3+CD4−CD8− (DNeg) cells, is significantly increased in lupus patients. Twenty-seven cases (53%) of pediatric SLE patients had elevated DNeg cells in their peripheral blood, which correlated with kidney function (R2 = 0.54). Significant infiltration of DNeg cells was observed in both adult and pediatric lupus kidneys by immunofluorescence. For the first time, this study provides direct evidence that DNeg cells facilitate kidney injury in preclinical 8-week-old MRL/lpr lupus mice. In lupus mice, the increase in DNeg cells tracked with worsening disease and correlated with kidney function (R2 = 0.85). Our results show that DNeg cells per se can cause kidney dysfunction, increase in number with increase in disease pathology, and could serve as a potential biomarker.



Lupus ◽  
2020 ◽  
Vol 29 (10) ◽  
pp. 1206-1215
Author(s):  
Sara L Haro ◽  
Erica F Lawson ◽  
Aimee O Hersh

Background Individuals with childhood-onset systemic lupus erythematosus (cSLE) must transfer from pediatric to adult care. The goal of this study was to examine disease activity and health-care utilization among young adults with cSLE who are undergoing or have recently completed the transfer to adult care. Methods The Pediatric Lupus Outcomes Study (PLOS) is a prospective longitudinal cohort study of young adults aged 18–30 diagnosed with cSLE. We conducted a cross-sectional analysis comparing 47 participants under the care of pediatric rheumatologists to 38 who had completed transfer to adult care. Demographics, disease manifestations, health- care utilization and transition readiness were compared between groups. Results Those in the post-transfer group had significantly lower medication usage and were less likely to have seen a rheumatologist in the past year. Disease manifestations, flare rates, and hospitalizations were similar between groups. Nearly a quarter of patients who had transferred to adult care reported difficulties with the process. Conclusion Post-transfer patients had lower health-care utilization as evidenced by less medication usage and lack of rheumatology follow-up, in spite of the fact that disease activity was similar in both groups. Future studies will assess longitudinal changes in disease activity and damage in this population.



2008 ◽  
Vol 6 (S1) ◽  
Author(s):  
R Jurencak ◽  
PN Tyrrell ◽  
SM Benseler ◽  
LT Hiraki ◽  
ED Silverman


2018 ◽  
Vol 70 (3) ◽  
pp. 420-427 ◽  
Author(s):  
Tamar B. Rubinstein ◽  
Wenzhu B. Mowrey ◽  
Norman T. Ilowite ◽  
Dawn M. Wahezi ◽  


2006 ◽  
Vol 25 (6) ◽  
pp. 297-309 ◽  
Author(s):  
Stephen D. Marks ◽  
Kjell Tullus ◽  
Neil J. Sebire


Sign in / Sign up

Export Citation Format

Share Document